On September 22, 2020, the United States marked a grim milestone in the ongoing COVID-19 pandemic, with the coronavirus having killed its 200,000th victim. The number of American casualties currently stands at 203,800, the highest of any single nation in the world, with the U.S. suffering over one-fifth of the
Health officials in both Russia and around the world are raising concerns over Moscow’s approval of a vaccine to be used against the SARS-CoV-2 coronavirus, despite not having finished critical Phase 3 clinical trials for the new treatment necessary to determine both the effectiveness and safety of the new inoculation.
In the mad scramble to find safe and effective drugs to treat patients suffering from COVID-19, the winners and losers amongst the litany of candidates are starting to emerge, with a previously-strong contender—hydroxychloroquine—falling from favor with the FDA, and another commonly-used drug seeing success in a major clinical trial. The
Health experts around the world are trying to unravel the puzzle as to why COVID-19 infections appear to be relatively benign in some individuals who contract the disease, while others have potentially fatal—and all too often outright deadly—reactions to the coronavirus. Toward that end, researchers are looking to the DNA